What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide.
This AI-Focused Cybersecurity Company Is Down 21% in a Year, so Why Is One Fund Buying? This cybersecurity firm delivers risk assessment and vulnerability management solutions to enterprise and government clients worldwide.
Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients.
What to Know About This Fund's $9 Million Exit From a Pawn Shop Giant Up Nearly 150% This Past Year EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods.
This Satellite Company Grew Revenue 80%. One Fund Just Disclosed Buying $6 Million Worth of Shares Satellogic delivers real-time Earth observation data and analytics, serving commercial and government clients across multiple industries.
Omada Health Q1 Earnings Call Highlights Omada Health (
NASDAQ:OMDA ) reported what executives described as a “milestone quarter” for the first quarter of 2026, highlighting 42% year-over-year revenue growth, expanding margins, and positive adjusted EBITDA alongside a raised full-year outlook.
On the earnings call, Co-Founder and CEO Sean D
Could This $14 Stock Be Your Ticket to Millionaire Status? This stock continues to benefit from GLP-1 tailwinds -- and now it trades at a reasonable valuation.
Voyager Stock Up 12% Post-IPO as One Fund Commits Nearly 30% of Assets Denver-based Voyager Technologies delivers advanced defense systems and space solutions to government and commercial clients worldwide.
Why a Nearly $30 Million Bet on BETA Stock Says More Than Its 26% Post-IPO Drop This electric aviation company develops aircraft, propulsion systems, and charging solutions for commercial and defense markets.
The Weight-Loss Craze Boosted The $186 Billion Telehealth Industry. What It Means For Investors. Telehealth companies are getting a fresh infusion of business thanks to obesity drugs. Find out which stocks are benefiting.
